These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2825909)
41. Delta and Mu receptor agonists correlate with greater depression of cardiac function than morphine sulfate in perfused rat hearts. Vargish T; Beamer KC Circ Shock; 1989 Mar; 27(3):245-51. PubMed ID: 2539920 [TBL] [Abstract][Full Text] [Related]
42. Comparative effects of opioid peptides on respiration and analgesia in rats. Flórez J; Pazos A Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613 [TBL] [Abstract][Full Text] [Related]
43. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Childers SR; Fleming L; Konkoy C; Marckel D; Pacheco M; Sexton T; Ward S Ann N Y Acad Sci; 1992 Jun; 654():33-51. PubMed ID: 1321574 [TBL] [Abstract][Full Text] [Related]
44. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Puttfarcken PS; Werling LL; Cox BM Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651 [TBL] [Abstract][Full Text] [Related]
45. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity. De Montis GM; Devoto P; Preti A; Tagliamonte A J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665 [TBL] [Abstract][Full Text] [Related]
46. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells. Bot G; Blake AD; Li S; Reisine T Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350 [TBL] [Abstract][Full Text] [Related]
47. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
48. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs. Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834 [TBL] [Abstract][Full Text] [Related]
49. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site. Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors. Schoffelmeer AN; Hogenboom F; Mulder AH Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):278-84. PubMed ID: 3035383 [TBL] [Abstract][Full Text] [Related]
51. Different subtypes of opioid receptors have different affinities for G-proteins. Polastron J; Jauzac P Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183 [TBL] [Abstract][Full Text] [Related]
52. Opioids act at mu-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance. Loose MD; Kelly MJ Brain Res; 1990 Apr; 513(1):15-23. PubMed ID: 2161696 [TBL] [Abstract][Full Text] [Related]
53. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice. Heyman JS; Mosberg HI; Porreca F NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989 [TBL] [Abstract][Full Text] [Related]
54. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
55. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460 [TBL] [Abstract][Full Text] [Related]
56. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
57. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
58. Opiate-induced seizures: a study of mu and delta specific mechanisms. Snead OC Exp Neurol; 1986 Aug; 93(2):348-58. PubMed ID: 3015659 [TBL] [Abstract][Full Text] [Related]
59. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues. Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345 [TBL] [Abstract][Full Text] [Related]
60. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites. Nijssen PC; Sexton T; Childers SR J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]